1. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Issue 2 (February 2022) Authors: Toback, Seth; Galiza, Eva; Cosgrove, Catherine; Galloway, James; Goodman, Anna L; Swift, Pauline A; Rajaram, Sankarasubramanian; Graves-Jones, Alison; Edelman, Jonathan; Burns, Fiona; Minassian, Angela M; Cho, Iksung; Kumar, Lakshmi; Plested, Joyce S; Rivers, E Joy; Robertson, Andreana; Dubovsky,... Journal: Lancet Issue: Volume 10:Issue 2(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Issue 10318 (18th December 2021) Authors: Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; va... Journal: Lancet Issue: Volume 398:Issue 10318(2021) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗